Precision Medicine: Access to Real-time Genetic Testing Data Impacts Prescriber Behavior following Minimally Invasive Stent Procedure

on .

Today, in a late-breaking featured clinical research session at the American College of Cardiology Scientific Sessions 2018, researchers from Penn Medicine present first-of-its-kind data on the impact of real-time CYP2C19 genotype results when prescribing antiplatelet drugs in the clinic.

Read full article on newswise.com